Indeks Tulisan

ebm-papst and Inovance Deepen Technical Exchange to Drive Industrial Innovation
XI'AN, China and SUZHOU, China, Aug. 3, 2026 /PRNewswire/ -- ebm-papst and Inovance recently joined forces for a two-way technical exchange under the theme "Together by Air Technology, Together by Innovation." The program took both teams to Inovance's Suzhou site and ebm-papst's national-level Green

Nippon Paint China Tampil Perdana di ARCHIDEX 2026, Pamerkan Inovasi untuk Industri Konstruksi
KUALA LUMPUR, Malaysia, 3 Agustus 2026 /PRNewswire/ -- Nippon Paint China untuk pertama kalinya berpartisipasi dalam ARCHIDEX 2026 yang berlangsung pada 29 Juli hingga 1 Agustus di Malaysia International Trade and Exhibition Centre (MITEC), Kuala Lumpur. Sebagai peserta pameran di China Exhibition Z

Steel Architectural Awards ASEAN 2026 Perkuat Kolaborasi Regional untuk Mendorong Keunggulan Arsitektur
SINGAPURA, 3 Agustus 2026 /PRNewswire/ -- Steel Architectural Awards ASEAN kembali hadir untuk kedua kalinya sebagai ajang yang mempertemukan para arsitek di Asia Tenggara guna mendorong keunggulan desain, berbagi pengetahuan, dan memperkuat kolaborasi di tingkat regional. Rangkaian program ini akan

Setelah Ekspansi ke Pasar Baru, Apa Langkah Berikutnya?
Ajang Land-Sea Economic Forum 2026 Bahas Strategi Lokalisasi KUALA LUMPUR, Malaysia, 3 Agustus 2026 /PRNewswire/ -- Artikel berita dari iChongqing: Hampir 200 perwakilan pemerintah, pelaku usaha, sektor keuangan, lembaga pemikir, dan media asal Tiongkok serta Malaysia berkumpul dalam ajang Land-Sea

Cboe Completes Sale of Cboe Australia to TMX Group
CHICAGO, Aug. 3, 2026 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), a leading global markets operator and pioneer in equity and index derivatives, today announced it has completed the sale of Cboe Australia (now TMX Australia Exchange) to TMX Group Limited (TMX Group). "Over the past year,

New Chemotherapy-Free Immunotherapy Combination for Follicular Lymphoma Listed on the PBS
Minjuvi® (tafasitamab), in combination with rituximab and lenalidomide, is the first and only chemotherapy-free CD19 and CD20 dual-targeted immunotherapy combination regimen listed on the Pharmaceutical Benefits Scheme (PBS) for adults with relapsed or refractory follicular lymphoma (R/R FL) (Grade

AI Can Write Research Papers. But Can Researchers Trust the Citations? Wispaper Says That's the Next Challenge for Academic AI
SINGAPORE, Aug. 2, 2026 /PRNewswire/ -- Artificial intelligence has transformed academic writing. Today, researchers can summarize hundreds of papers, generate literature reviews, and even draft complete manuscripts in minutes. But as AI becomes an indispensable research tool, a new challenge is eme
China has potential to lead global humanoid robotics: Founder of EngineAI
GUANGZHOU, China, Aug. 1, 2026 /PRNewswire/ -- This is a news report from South: Guangdong has been rolling out the "Beacon Over Lingnan" video series across major online platforms since June 27. The fifth episode features a conversation with Zhao Tongyang, Founder & CEO of EngineAI Robotics Tech

Guangdong Museum shows China's floral patterns that predate luxury monograms by centuries
GUANGZHOU, China, Aug. 1, 2026 /PRNewswire/ -- This is a news report from South: The recent trademark dispute between Louis Vuitton and Chinese tea brand Molly Tea has sparked widespread discussion about floral motifs, brand identity and the origins of decorative design. Yet centuries before monogra

Korean F&B Brand Reddog Posts 88% Revenue Growth, 143% Operating Profit Jump in H1 2026
Six-month group consolidated revenue reaches IDR 198.5 billion (approximately SG$14.3 million) — equal to 97% of full-year 2025 revenue — while operating profit rises 143% year on year Company in discussions with multiple Indonesian securities firms toward an Indonesia Stock Exchange listing targete
Masuk tirto.id








